ATCO.A

164.55

+0.34%↑

SWED.A

253.9

+0.28%↑

SCA.A

128.45

+0.67%↑

SHB.B

199.7

+1.27%↑

LATOB

266.6

-0.41%↓

ATCO.A

164.55

+0.34%↑

SWED.A

253.9

+0.28%↑

SCA.A

128.45

+0.67%↑

SHB.B

199.7

+1.27%↑

LATOB

266.6

-0.41%↓

ATCO.A

164.55

+0.34%↑

SWED.A

253.9

+0.28%↑

SCA.A

128.45

+0.67%↑

SHB.B

199.7

+1.27%↑

LATOB

266.6

-0.41%↓

ATCO.A

164.55

+0.34%↑

SWED.A

253.9

+0.28%↑

SCA.A

128.45

+0.67%↑

SHB.B

199.7

+1.27%↑

LATOB

266.6

-0.41%↓

ATCO.A

164.55

+0.34%↑

SWED.A

253.9

+0.28%↑

SCA.A

128.45

+0.67%↑

SHB.B

199.7

+1.27%↑

LATOB

266.6

-0.41%↓

Search

Biotage AB

Chiusa

141.9 0.35

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

141.4

Massimo

142.1

Metriche Chiave

By Trading Economics

Entrata

-154M

4M

Vendite

-197M

385M

P/E

Media del settore

44.606

24.598

EPS

0.325

Rendimento da dividendi

1.16

Margine di Profitto

1.039

Dipendenti

622

EBITDA

-194M

28M

Dividendi

By Dow Jones

Rendimento da dividendi

Media del settore

1.16%

4.30%

Utili prossimi

16 lug 2025

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

4.1B

11B

Apertura precedente

141.55

Chiusura precedente

141.9

Biotage AB Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

22 apr 2025, 06:50 UTC

Acquisizioni, Fusioni, Takeovers

KKR Launches $1.2 Billion Takeover Bid For Swedish Life-Sciences Company Biotage

22 apr 2025, 06:04 UTC

Acquisizioni, Fusioni, Takeovers

KKR: Offer Price Represents 60% Premium to Thursday's Closing Price

22 apr 2025, 06:03 UTC

Acquisizioni, Fusioni, Takeovers

KKR: Biotage Board Recommends Shareholders Accept Offer

22 apr 2025, 06:02 UTC

Acquisizioni, Fusioni, Takeovers

KKR: Offer Values Biotage at SEK11.61B

22 apr 2025, 06:02 UTC

Acquisizioni, Fusioni, Takeovers

KKR Makes SEK145 a Share Bid For Biotage

Confronto tra pari

Modifica del prezzo

Biotage AB Previsione

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo Biotage AB

Biotage AB (publ) provides solutions and products in the areas of drug discovery and development, analytical testing, and water and environmental testing. The company offers organic and peptide synthesis solutions; flash chromotherapy, evaporation, and work-up products; flash systems; sample preparation products; plasmid purification solutions; oligo synthesis solutions; and metal scavengers and reagents, as well as accessories and spare parts. It also provides sample preparation solutions in the clinical and bioanalytical, forensic and toxicology, doping control animal and human, environment, and food and agriculture areas, as well as consumables and systems; protein purification solutions, including antibody and tagged proteins purification, automation systems, and custom packing service, as well as ion exchange, reversed phase, normal phase, and gel filtration PhyTip columns. The company sells its products to pharmaceutical and biotechnical companies, contract research and manufacturing organizations, diagnostics, clinical, environmental protection, food safety, clinical, forensic, and academic laboratories industries. It operates in more than 80 countries, which include Americas, Europe, the Middle East, Africa, and Asia Pacific. Biotage AB (publ) was founded in 1969 and is headquartered in Uppsala, Sweden.